Prestige Consumer Healthcare, Inc. (PBH)
46.19
+0.87
(+1.92%)
USD |
NYSE |
Nov 13, 16:00
46.16
-0.04
(-0.08%)
After-Hours: 19:59
Prestige Consumer Healthcare Shareholders Equity (Quarterly) : 1.945B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.945B |
| June 30, 2026 | 1.917B |
| March 31, 2026 | 1.888B |
| December 31, 2025 | 1.829B |
| September 30, 2025 | 1.825B |
| June 30, 2025 | 1.855B |
| March 31, 2025 | 1.835B |
| December 31, 2024 | 1.788B |
| September 30, 2024 | 1.732B |
| June 30, 2024 | 1.681B |
| March 31, 2024 | 1.655B |
| December 31, 2023 | 1.601B |
| September 30, 2023 | 1.536B |
| June 30, 2023 | 1.480B |
| March 31, 2023 | 1.447B |
| December 31, 2022 | 1.687B |
| September 30, 2022 | 1.620B |
| June 30, 2022 | 1.585B |
| March 31, 2022 | 1.578B |
| December 31, 2021 | 1.518B |
| September 30, 2021 | 1.462B |
| June 30, 2021 | 1.416B |
| March 31, 2021 | 1.358B |
| December 31, 2020 | 1.323B |
| September 30, 2020 | 1.278B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.227B |
| March 31, 2020 | 1.171B |
| December 31, 2019 | 1.156B |
| September 30, 2019 | 1.113B |
| June 30, 2019 | 1.102B |
| March 31, 2019 | 1.096B |
| December 31, 2018 | 1.233B |
| September 30, 2018 | 1.193B |
| June 30, 2018 | 1.162B |
| March 31, 2018 | 1.179B |
| December 31, 2017 | 1.217B |
| September 30, 2017 | 895.97M |
| June 30, 2017 | 858.55M |
| March 31, 2017 | 822.55M |
| December 31, 2016 | 799.86M |
| September 30, 2016 | 774.64M |
| June 30, 2016 | 737.48M |
| March 31, 2016 | 744.34M |
| December 31, 2015 | 720.94M |
| September 30, 2015 | 685.76M |
| June 30, 2015 | 662.72M |
| March 31, 2015 | 627.62M |
| December 31, 2014 | 608.94M |
| September 30, 2014 | 594.04M |
| June 30, 2014 | 585.81M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 1.062B |
| Phibro Animal Health Corp. | 417.67M |
| Structure Therapeutics, Inc. | 1.222B |
| ANI Pharmaceuticals, Inc. | 637.11M |
| Corcept Therapeutics, Inc. | 833.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.722B |
| Total Liabilities (Quarterly) | 2.777B |
| Debt to Equity Ratio | 1.094 |
| Current Ratio | 2.921 |
| Net Debt Paydown Yield | -9.98% |